Cite Filings / REPL
Feed Companies Filings Check
Sign in

CIK 0001737953

  • Non-accelerated filer
  • Smaller reporting company

Replimune Group, Inc.

Sign in to watch
Ticker
REPL
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Mar 31
Incorporated
DE
Entity type
Operating
EIN
822082553
Phone
+1 781-222-9600
Business address
500 UNICORN PARK, WOBURN, MA, 01801
Filings Financials Insiders Search text
All 663 Financials 150 Shareholder Meetings 10 Executive Compensation 131 Insider Trading 316 Beneficial Ownership Interest 87 Business Combinations 114 Public Offerings 48 Mutual Funds and ETFs 8 Others 60
›
Filed in
  1. No filings match these filters. Clear filters
  2. S-1/A Offering Registration Statement 2018-07-10
  3. CORRESP Other Correspondence Between Filers and SEC Staff 2018-06-29
  4. UPLOAD Other SEC-generated Letter 2018-06-28
  5. CORRESP Other Correspondence Between Filers and SEC Staff 2018-06-26
  6. S-1/A Offering Registration Statement 2018-06-26
  7. UPLOAD Other SEC-generated Letter 2018-06-25
  8. S-1 Offering Registration Statement 2018-06-22
  9. UPLOAD Other SEC-generated Letter 2018-06-08

Page 3 of 3 · 48 filings

First Previous Next Last

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…